Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapies to modulate gene expression for genetically defined diseases including facioscapulohumeral muscular dystrophy (FSHD) and sickle cell disease.
Company Info
Sector:Rare disease / Genomics
Headquarters:Cambridge, Massachusetts, USA
Founded:2016
Website:www.fulcrumtx.com/
Recent News
No recent news updates available for this company.